EU re-inspection delay
EU audit (Hungary) expected in May-June 2026; any delay could postpone regulated market revenue.
LINCOLNPHARMACEUTICALS / bear-case history
Track the concerns that keep returning.
Lincoln Pharmaceuticals · risk themes across the available quarters.
Research layer active
Bear-case history
Risks carried through the record.
medium
High other income dependence
Other income (forex gains, investment returns) is volatile and contributed ~50% of PBT in 9M; sustainability uncertain.
Inorganic growth execution risk
Management is holding cash for acquisitions; if no suitable target found, cash drag may persist.
Geopolitical risk in Africa
Africa contributes 40% of exports; currency fluctuations and payment delays are inherent risks.